Comparison

Osteogenic Growth Peptide, OGP European Partner

Manufacturer GenScript
Category
Type Peptides
Specific against other
Amount 5.0mg
Item no. RP20311-5
Targets FOXD3
eClass 6.1 34160400
eClass 9.0 32160409
Available
Description
The osteogenic growth peptide OGP (ALKRQGRTLYGFGG) is a key factor in the mechanism of the systemic osteogenic response to local bone marrow injury. OGP level is increased in the serum in vivo during osteogenic reactions in the form of OGP-OGP binding protein complex. When it is applied to pre-osteoblast in vitro, OGP promotes bone cell proliferation and differentiation, which is indicated by increasing ALP Alkaline phosphatase activity. When it is administered in vivo, OGP stimulates osteogenesis and hematopoiesis.
Storage
Store at -20C. Keep tightly closed. Store in a cool dry place.
Product Origin
USA

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5.0mg
Available: In stock
available

Delivery expected until 4/18/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close